PANI, FABIANA
 Distribuzione geografica
Continente #
EU - Europa 79.790
NA - Nord America 2.486
AS - Asia 960
SA - Sud America 156
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 83.413
Nazione #
IT - Italia 78.968
US - Stati Uniti d'America 2.425
CN - Cina 413
SG - Singapore 351
SE - Svezia 176
UA - Ucraina 166
BR - Brasile 132
DE - Germania 111
FR - Francia 104
GB - Regno Unito 83
VN - Vietnam 60
FI - Finlandia 47
NL - Olanda 35
CA - Canada 28
KR - Corea 26
IN - India 25
MX - Messico 24
PL - Polonia 18
BE - Belgio 15
RU - Federazione Russa 15
TR - Turchia 15
IR - Iran 13
JP - Giappone 9
ES - Italia 8
EU - Europa 7
HK - Hong Kong 7
IQ - Iraq 7
AR - Argentina 6
EC - Ecuador 6
PT - Portogallo 6
BD - Bangladesh 5
CH - Svizzera 5
IE - Irlanda 5
ZA - Sudafrica 5
AT - Austria 4
IL - Israele 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
CO - Colombia 3
PK - Pakistan 3
RO - Romania 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
JM - Giamaica 2
MA - Marocco 2
PY - Paraguay 2
SA - Arabia Saudita 2
VE - Venezuela 2
AU - Australia 1
BO - Bolivia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MK - Macedonia 1
ML - Mali 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 83.413
Città #
Cagliari 74.002
Uta 1.118
Rome 304
Milan 296
Ashburn 229
Chandler 193
Singapore 180
Woodbridge 172
Dallas 149
Fairfield 142
Nyköping 124
Houston 110
Dearborn 105
Beijing 94
Boardman 91
Wilmington 85
Ann Arbor 72
Naples 72
New York 71
Seattle 70
Bologna 58
Shanghai 57
Cambridge 56
Florence 54
Los Angeles 53
Jacksonville 43
Santa Clara 42
Palermo 40
Boston 38
Nanjing 36
Turin 36
Bari 34
Munich 34
Catania 33
Helsinki 33
The Dalles 29
Seoul 25
Genoa 24
Padova 22
Atlanta 20
Buffalo 20
Parma 19
Toronto 19
San Diego 18
San Mateo 18
Torino 18
Ho Chi Minh City 17
Dong Ket 16
Guangzhou 16
Zhengzhou 16
Avellino 15
Hebei 15
London 15
Pescara 15
Redwood City 15
Shenyang 15
São Paulo 15
Jiaxing 14
Reggio Calabria 14
Mountain View 13
Nanchang 13
Tianjin 13
Brescia 12
Monza 12
Lauterbourg 11
Messina 11
Perugia 11
Salerno 11
Sassari 11
Verona 11
Baltimore 10
Chicago 10
Foggia 10
Frankfurt am Main 10
Genova 10
Montecchio Maggiore 10
Rimini 10
Varazze 10
Bergamo 9
Brussels 9
Hanoi 9
Segrate 9
Augusta 8
Brooklyn 8
Changsha 8
Hefei 8
Leawood 8
Lissone 8
Modena 8
Mumbai 8
Orange 8
Phoenix 8
Tokyo 8
Udine 8
Como 7
Giugliano in Campania 7
Hong Kong 7
Livorno 7
Napoli 7
Nichelino 7
Totale 79.139
Nome #
L’iperplasia delle cellule “c” parafollicolari senza mutazione del protooncogene ret: descrizione e implicazioni diagnostiche di alcuni casi clinici. 4.897
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.838
Thyrospheres from B-CPAP cell line with BRAF and TERT promoter mutations have different functional and molecular features than parental cells 3.376
Associazione tra carcinoma papillare della tiroide e tiroidite cronica autoimmune: nuove conferme da un ampio studio prospettico. 3.151
High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up 3.132
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.941
Risultati di un ampio studio prospettico sull’associazione tra la tiroidite di Hashimoto e il carcinoma papillare della tiroide. 2.920
Association between autoimmune thyroiditis and papillary thyroid carcinoma: new confirmations from a large prospective study. 2.920
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.913
Score ecografico del rischio di malignità dei noduli tiroidei (TI-RADS): risultati citologici di uno studio prospettico di noduli con tiroidite di Hashimoto vs noduli senza tiroidite di Hashimoto. 2.866
Characterizing the three-dimensional organization of telomeres in papillary thyroid carcinoma cells 2.775
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.629
Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies 2.623
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.587
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report 2.456
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.432
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.405
Thyroid dysfunction in patients with metastatic carcinoma treated with Sunitinib: is thyroid autoimmunity involved? 2.335
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.303
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 2.300
HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB 2.208
The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience 2.199
Higher prevalence of thyroid cancer in patients with thyroid nodules (TN) and Hashimoto’s Thyroiditis (HT) at the first clinical evaluation compared to TN patients without thyroid autoimmunity and HT patients without TN followed-up for 1-9 years. 2.180
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.097
Ipotiroidismo e autoimmunità tiroidea in pazienti affetti da carcinoma renale metastatico trattati con sunitinib con un follow-up di 30 mesi. 2.081
Prevalence of thyroid cancer in patients with hashimoto’s thyroiditis with or without nodules at the first clinical evaluation and in the subsequent follow-up. 1.997
Differenze nella prevalenza del carcinoma papillare della tiroide (PTC) nei pazienti con noduli tiroidei (NT) associati a tiroidite di Hashimoto (HT) alla prima diagnosi rispetto ai pazienti con NT senza TH e ai pazienti con TH esordita prima dei NT. 1.976
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 1.965
Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a single centre experience. 1.936
Hashimoto’s thyroiditis and thyroid cancer: a case-control study of unselected patients with thyroid nodules submitted to cytological and hystological examination. 1.915
Thyroid dysfunction and ultrasonography features in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Preliminary results from a prospective cohort study. 1.320
Embolization of iliac metastasis during lenvatinib treatment in patient with advanced Hürthle cell thyroid carcinoma 1.232
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome 770
Caratteristiche cliniche, endocrine, e metaboliche di donne non obese affette da sindrome dell'ovaio policistico (PCOS) dopo sei cicli di trattamento con la formulazione contraccettiva estroprogestinica orale monofasica contenente 30 mcg di etinilestradiolo (EE) e 2 mg di clormadinone acetato (CMA) 759
CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients. 139
Totale 83.573
Categoria #
all - tutte 97.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.884 0 0 0 0 0 2.818 1.479 1.421 721 1.424 1.253 768
2021/20224.549 598 367 245 458 349 338 287 239 444 437 390 397
2022/20236.015 560 912 896 460 414 375 306 419 424 369 574 306
2023/20246.317 405 242 260 391 568 958 981 569 306 402 624 611
2024/202510.171 2.590 2.943 1.199 1.020 559 620 717 74 136 113 108 92
2025/20261.156 222 110 241 159 263 161 0 0 0 0 0 0
Totale 83.573